Literature DB >> 20802542

Expression of antiangiogenic prolactin fragments in the placentas of women with pregnancy induced hypertension.

Akio Masumoto1, Hisashi Masuyama, Norio Takamoto, Yoichiro Akahori, Yuji Hiramatsu.   

Abstract

It has been reported that prolactin (PRL) is cleaved to 14 or 16 kDa fragments by cathepsin D in vitro and in vivo, and that such fragments exhibit antiangiogenic and proapoptotic properties. The aim of this study was to investigate the relationship between pregnancy induced hypertension (PIH) and the placental expression of antiangiogenic PRL fragments and cathepsin D. Placental expression of PRL fragments and cathepsin D was evaluated by Western blot analysis in a group of 9 pregnant women consisting of 5 normal pregnancies and 4 severe PIH cases. Antiangiogenic PRL fragments were detected in 4 placental samples from all PIH cases but not detected in those from normal pregnancies (p<0.05). The expression of cathepsin D in PIH placentas was significantly lower than that in those without PIH (p<0.05), while the placental expression of procathepsin D was significantly greater in PIH cases than in the normal pregnancies (p<0.05). These data suggest that antiangiogenic PRL fragments in the placenta may be present only in PIH cases, and that PRL fragments in the placenta might be implicated in the pathophysiology of PIH.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802542     DOI: 10.18926/AMO/40133

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  4 in total

Review 1.  Prolactin and its significance in the placenta.

Authors:  Meenakshi Rana; Sidhant Jain; Pooja Choubey
Journal:  Hormones (Athens)       Date:  2022-05-11       Impact factor: 2.885

Review 2.  Principles of the prolactin/vasoinhibin axis.

Authors:  Jakob Triebel; Thomas Bertsch; Cornelius Bollheimer; Daniel Rios-Barrera; Christy F Pearce; Michael Hüfner; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-26       Impact factor: 3.619

Review 3.  From Bench to Bedside: Translating the Prolactin/Vasoinhibin Axis.

Authors:  Jakob Triebel; Maria Ludivina Robles-Osorio; Renata Garcia-Franco; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-11       Impact factor: 5.555

4.  Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.

Authors:  Jakob Triebel; Christin J Friedrich; Andreas Leuchs; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-06       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.